#protein folding
Sep 2026
Targeted RPT of CEACAM5-Expressing Human Xenografts Using an Albumin-Binding Domain-Fused C9 Affibody: Proof-of-Principle Study.
ABD035-C9-C9-DOTA is a promising candidate for the development of targeted RPT of CEACAM5-expressing tumors and a significant increase in the survival of tumor-bearing mice and mild, transient toxicity is demonstrated.
Ruo-Nan Li, E. Papalanis, M. Oroujeni et al.
· Journal of Nuclear Medicine · 0 citations